1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Market Size Growth Rate by Type (2022-2028)
1.2.2 Zinc finger nucleases (ZFNs)
1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.4 CRISPR-Cas system
1.3 Market by Application
1.3.1 Global Gene Editing Market Share by Application (2022-2028)
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered 2 Executive Summary
2.1 Global Gene Editing Market Size
2.2 Gene Editing Market Size by Regions
2.2.1 Gene Editing Growth Rate by Regions (2022-2028)
2.2.2 Gene Editing Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases 3 Key Players
3.1 Gene Editing Revenue by Players (2022 & 2028)
3.2 Gene Editing Key Players Headquarters and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application
4.1 Global Gene Editing Market Size by Type (2022-2028)
4.2 Global Gene Editing Market Size by Application (2022-2028) 5 North America
5.1 North America Gene Editing Market Forecast (2022-2028)
5.2 Gene Editing Key Players in North America
5.3 North America Gene Editing Market Size by Type
5.4 North America Gene Editing Market Size by Application 6 Europe
6.1 Europe Gene Editing Market Forecast (2022-2028)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application 7 Asia-Pacific
7.1 Asia-Pacific Gene Editing Market Forecast (2022-2028)
7.2 Gene Editing Key Players in Asia-Pacific
7.3 Asia-Pacific Gene Editing Market Size by Type
7.4 Asia-Pacific Gene Editing Market Size by Application 8 Rest of World
8.1 Latin America
8.1.1 Latin America Gene Editing Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Gene Editing Market Analysis
8.2.2 Key Players in Middle East & Africa 9 International Player Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Thermo Fisher Scientific Description and Business Overview
9.1.3 Thermo Fisher Scientific Gene Editing Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2022 & 2028)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
9.2.1 Merck Company Details
9.2.2 Merck Description and Business Overview
9.2.3 Merck Gene Editing Introduction
9.2.4 Merck Revenue in Gene Editing Business (2022 & 2028)
9.2.5 Merck Recent Development
9.3 Horizo??n Discovery
9.3.1 Horizo??n Discovery Company Details
9.3.2 Horizo??n Discovery Description and Business Overview
9.3.3 Horizo??n Discovery Gene Editing Introduction
9.3.4 Horizo??n Discovery Revenue in Gene Editing Business (2022 & 2028)
9.3.5 Horizo??n Discovery Recent Development
9.4 Sangamo BioSciences
9.4.1 Sangamo BioSciences Company Details
9.4.2 Sangamo BioSciences Description and Business Overview
9.4.3 Sangamo BioSciences Gene Editing Introduction
9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2022 & 2028)
9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
9.5.1 Integrated DNA Technologies Company Details
9.5.2 Integrated DNA Technologies Description and Business Overview
9.5.3 Integrated DNA Technologies Gene Editing Introduction
9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2022 & 2028)
9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
9.6.1 Lonza Company Details
9.6.2 Lonza Description and Business Overview
9.6.3 Lonza Gene Editing Introduction
9.6.4 Lonza Revenue in Gene Editing Business (2022 & 2028)
9.6.5 Lonza Recent Development
9.7 New England Biolabs
9.7.1 New England Biolabs Company Details
9.7.2 New England Biolabs Description and Business Overview
9.7.3 New England Biolabs Gene Editing Introduction
9.7.4 New England Biolabs Revenue in Gene Editing Business (2022 & 2028)
9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
9.8.1 OriGene Technologies Company Details
9.8.2 OriGene Technologies Description and Business Overview
9.8.3 OriGene Technologies Gene Editing Introduction
9.8.4 OriGene Technologies Revenue in Gene Editing Business (2022 & 2028)
9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
9.9.1 Transposagen Biopharmaceuticals Company Details
9.9.2 Transposagen Biopharmaceuticals Description and Business Overview
9.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2022 & 2028)
9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
9.10.1 Editas Medicine Company Details
9.10.2 Editas Medicine Description and Business Overview
9.10.3 Editas Medicine Gene Editing Introduction
9.10.4 Editas Medicine Revenue in Gene Editing Business (2022 & 2028)
9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
9.11.1 CRISPR Therapeutics Company Details
9.11.2 CRISPR Therapeutics Description and Business Overview
9.11.3 CRISPR Therapeutics Gene Editing Introduction
9.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2022 & 2028)
9.11.5 CRISPR Therapeutics Recent Development
9.12 RGen Solutions
9.12.1 RGen Solutions Company Details
9.12.2 RGen Solutions Description and Business Overview
9.12.3 RGen Solutions Gene Editing Introduction
9.12.4 RGen Solutions Revenue in Gene Editing Business (2022 & 2028)
9.12.5 RGen Solutions Recent Development
9.13 Sigma-Aldrich
9.13.1 Sigma-Aldrich Company Details
9.13.2 Sigma-Aldrich Description and Business Overview
9.13.3 Sigma-Aldrich Gene Editing Introduction
9.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2022 & 2028)
9.13.5 Sigma-Aldrich Recent Development
9.14 GeneCopoeia
9.14.1 GeneCopoeia Company Details
9.14.2 GeneCopoeia Description and Business Overview
9.14.3 GeneCopoeia Gene Editing Introduction
9.14.4 GeneCopoeia Revenue in Gene Editing Business (2022 & 2028)
9.14.5 GeneCopoeia Recent Development
9.15 Genscript Biotech
9.15.1 Genscript Biotech Company Details
9.15.2 Genscript Biotech Description and Business Overview
9.15.3 Genscript Biotech Gene Editing Introduction
9.15.4 Genscript Biotech Revenue in Gene Editing Business (2022 & 2028)
9.15.5 Genscript Biotech Recent Development 10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints 11 Key Findings in This Report 12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
